An immunocompetent host with blood-disseminated Aspergillus versicolor spondylitis: a case report and literature review

Shuangxia Dong,Qianding Lin,Xinjian Dai,Zhou Lin
DOI: https://doi.org/10.1177/03000605241234574
2024-04-11
Journal of International Medical Research
Abstract:Journal of International Medical Research, Volume 52, Issue 4, April 2024. Blood-disseminated Aspergillus spondylitis in immunocompetent individuals is rare. The clinical, imaging, and pathological manifestations of this condition are not specific. Therefore, this disease is prone to misdiagnosis and a missed diagnosis. Systemic antifungal therapy is the main treatment for Aspergillus spondylitis. We report a case of blood-disseminated Aspergillus versicolor spondylitis in a patient with normal immune function. The first antifungal treatment lasted for 4 months, but Aspergillus spondylitis recurred a few months later. A second antifungal treatment course was initiated for at least 1 year, and follow-up has been ongoing. Currently, there has been no recurrence.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?